Giant Biogene Pre-IPO - The Negatives - Co-Founders Have Already Cashed in US$1bn+
Giant Biogene (GB) aims to raise around US$500m in its Hong Kong IPO. It is the largest recombinant collagen based products maker in China.
555 Views
Giant Biogene Pre-IPO - The Positives - Fast Growth and Juicy Margins
Giant Biogene aims to raise around US$500m in its Hong Kong IPO. It is a leader in the recombinant collagen market in China.
608 Views
Hong Kong Connect Flows: Tencent, Wuxi Biologics, China Mobile
Inflows from mainland investors to Hong Kong stocks have been positive for the past 12 weeks. We highlight flows for Tencent, Wuxi Biologics, and...
448 Views
ECM Weekly (24th Jul 2022) - ANZ, Zomato, LG Energy, Xtep, SoCar, WCP, Thai Life, Beneunder, Ubox
Aequitas Research puts out a weekly update on the deals that were covered by the team recently along with updates for upcoming IPOs.
735 Views
Xtep International Placement - Parent Trimming at ATHs, Last Deal Didn’t Do Well
Group Success Investments is looking to raise up to US$133m by trimming its holdings in Xtep International (1368 HK). Short interest on the stock...
427 Views